Get Premium to unlock powerful stock data
Kala Pharmaceuticals Inc logo

Kala Pharmaceuticals Inc

$ 0.35 +0.0072 (+2.07%) 02:46 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 25.68M
Enterprise V:
$ 35.77M
Volume:
1.88M
Avg Vol (2M):
1.44M
Also Trade In:
Volume:
1.88M
Market Cap $:
25.68M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.44M
Enterprise Value $:
35.77M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Kala Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
1167 Massachusetts Avenue, Arlington, MA, USA, 02476
Description
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS.
Name Current Vs Industry Vs History
Cash-To-Debt 0.87
Equity-to-Asset -0.05
Debt-to-Equity -15.28
Debt-to-EBITDA -0.59
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.35
Distress
Grey
Safe
Beneish M-Score -3.67
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 8.1
9-Day RSI 17.09
14-Day RSI 23.8
6-1 Month Momentum % -62.88
12-1 Month Momentum % -87.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3
Quick Ratio 2.68
Cash Ratio 2.14
Days Inventory 765.37
Days Sales Outstanding 508.17
Days Payable 401.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.6

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 55.95
Operating Margin % -1198.05
Net Margin % -1552.9
ROE % -271.73
ROA % -81.53
ROIC % -207.48
ROC (Joel Greenblatt) % -641.81
ROCE % -91.65

Financials

KALA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:KALA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.346
EPS (TTM) ($) -2.15
Beta 0.47
Volatility % 144.25
14-Day RSI 23.8
14-Day ATR ($) 0.114254
20-Day SMA ($) 0.656605
12-1 Month Momentum % -87.07
52-Week Range ($) 0.3406 - 6.77
Shares Outstanding (Mil) 72.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kala Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More